Sanguine BioSciences, Inc. announced that it has raised $10 million in its seed round of funding on February 21, 2013. The round was led by new investors Heliant Ventures and Invent Ventures, Inc.

On February 21, 2013, Sanguine BioSciences, Inc. closed the transaction.